The sell-side on Wall Steet is predicting Amicus Therapeutics, Inc. (NASDAQ:FOLD) to grow at an accelerated rate over the next five years. Sell-side analysts are looking for the company to grow 31.70% over the next year and 36.00% over the next five years.
EPS measures what each share is worth and also indicates how much money their sharehoders would gain if the company was to pay out all of its profits. Amicus Therapeutics, Inc.’s trailing 12- months EPS is -1.52. Last year, their EPS growth was -23.80% and their EPS growth over the past five years was -3.00%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s stock was 98.79%. Last week, it was 18.32%, 35.99% over the last quarter, and 105.83% for the past half-year.
Over the past 50 days, Amicus Therapeutics, Inc. stock was -2.22% off of the high and 54.76% removed from the low. Their 52-Week High and Low are noted here. -2.22% (High), 124.94%, (Low).
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s performance this year to date is 98.79%. The stock has performed 18.32% over the last seven days, 27.65% over the last thirty, and 35.99% over the last three months. Over the last six months, Amicus Therapeutics, Inc.’s stock has been 105.83% and 75.80% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 1.50 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $12.92 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.